Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-04-27 | 2020-05-21 | 113330 |
| BETOPTIC S | 0.25% | SUSPENSION | Resolved | 2020-05-21 | 2020-08-28 | 115462 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2017-11-28 | 2018-01-08 | 30982 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2018-10-17 | 2018-12-18 | 64629 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2022-01-12 | 2022-03-04 | 152535 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2024-01-15 | 2024-02-22 | 216049 |
| MAXITROL | 1MG 6000UNIT 3.5MG | SUSPENSION | Resolved | 2018-11-23 | 2019-02-05 | 67487 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| FLAREX | 0.1% | SUSPENSION | Resolved | 2017-07-13 | 2017-07-27 | 15722 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163678 |
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |